Variant report
Variant | esv1804579 |
---|---|
Chromosome Location | chr6:120618914-120658827 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560595336 | chr6:120618951-120618952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531565366 | chr6:120618954-120618955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9401229 | chr6:120618966-120618967 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs571402407 | chr6:120618967-120618968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144528828 | chr6:120618984-120618985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs28549346 | chr6:120618990-120618991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114382001 | chr6:120618995-120618996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547503017 | chr6:120618996-120618997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189210692 | chr6:120619006-120619007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545704443 | chr6:120619017-120619018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs72962645 | chr6:120619040-120619041 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs532081553 | chr6:120619059-120619060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs148460611 | chr6:120619073-120619074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192690588 | chr6:120619109-120619110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562571975 | chr6:120619139-120619140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577798639 | chr6:120619218-120619219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112763452 | chr6:120619236-120619237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184155847 | chr6:120619238-120619239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188464428 | chr6:120619267-120619268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574100862 | chr6:120619276-120619277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548631892 | chr6:120619278-120619279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377494749 | chr6:120619290-120619291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113340409 | chr6:120619293-120619294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570318831 | chr6:120619294-120619295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563030551 | chr6:120619306-120619307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565671041 | chr6:120619312-120619313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs11153874 | chr6:120619356-120619357 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs531315991 | chr6:120619373-120619374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544979696 | chr6:120619382-120619383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564902681 | chr6:120619395-120619396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181069466 | chr6:120619399-120619400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112053154 | chr6:120619407-120619408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113976756 | chr6:120619455-120619456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs2927905 | chr6:120619459-120619460 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs567431225 | chr6:120619482-120619483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11153875 | chr6:120619490-120619491 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs534789736 | chr6:120619507-120619508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549210753 | chr6:120619519-120619520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369563671 | chr6:120619563-120619564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182160228 | chr6:120620819-120620820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73769744 | chr6:120620823-120620824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs567717134 | chr6:120620826-120620827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs61265678 | chr6:120620844-120620845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576534087 | chr6:120620862-120620863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187338948 | chr6:120620900-120620901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145319841 | chr6:120620901-120620902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368537108 | chr6:120620962-120620963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs76279745 | chr6:120620972-120620973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs76894688 | chr6:120620973-120620974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9385126 | chr6:120620995-120620996 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 18698023 | CNVD |
Mental retardation | 18854857 | CNVD |
Leukemia | 18688285 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Breast cancer | 21611746 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:120617600-120619200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr6:120618000-120619000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr6:120618400-120619200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr6:120618400-120619600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr6:120618600-120619000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr6:120620800-120631600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr6:120628200-120628600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr6:120628200-120628600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr6:120651800-120652000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr6:120651800-120652200 | Enhancers | HepG2 | liver |